Signatures of H3K4me3 modification predict cancer immunotherapy response and identify a new immune checkpoint-SLAMF9
Abstract H3 lysine 4 trimethylation (H3K4me3) modification and related regulators extensively regulate various crucial transcriptional courses in health and disease. However, the regulatory relationship between H3K4me3 modification and anti-tumor immunity has not been fully elucidated. We identified...
Saved in:
Main Authors: | Tao Fan, Chu Xiao, Ziqin Deng, Shuofeng Li, He Tian, Yujia Zheng, Bo Zheng, Chunxiang Li, Jie He |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Respiratory Research |
Online Access: | https://doi.org/10.1186/s12931-024-03093-6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bisphenol B restrains rat leydig cell function via H3K27me3/H3K9me3 histone modifications
by: Jiayi He, et al.
Published: (2025-02-01) -
New epigenome players in the regulation of PCSK9-H3K4me3 and H3K9ac alterations by statin in hypercholesterolemia
by: Sushmitha Duddu, et al.
Published: (2025-01-01) -
Mitochondria-targeted photothermal-chemodynamic therapy enhances checkpoint blockade immunotherapy on colon cancer
by: Benchao Zheng, et al.
Published: (2025-04-01) -
Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
by: Francesca De Felice, et al.
Published: (2015-01-01) -
H3K79me3T80ph is a Novel Histone Dual Modification and a Mitotic Indicator in Melanoma
by: Danielle R. Martinez, et al.
Published: (2012-01-01)